These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22978629)

  • 41. [Direct costs for Parkinson's treatment in private neurology practices in Berlin].
    Ehret R; Balzer-Geldsetzer M; Reese JP; Dodel I; Becker E; Christopher A; Friedrich H; Kraemer S; Lüer W; Müngersdorf M; Puzich R; Rohr A; Schultes-Platzek I; Siefjediers V; Tiel-Wilck K; Oertel WH; Dodel R
    Nervenarzt; 2009 Apr; 80(4):452-8. PubMed ID: 19252890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom.
    Findley L; Aujla M; Bain PG; Baker M; Beech C; Bowman C; Holmes J; Kingdom WK; MacMahon DG; Peto V; Playfer JR
    Mov Disord; 2003 Oct; 18(10):1139-45. PubMed ID: 14534917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost of illness and disease severity in a cohort of French patients with Parkinson's disease.
    LePen C; Wait S; Moutard-Martin F; Dujardin M; Ziégler M
    Pharmacoeconomics; 1999 Jul; 16(1):59-69. PubMed ID: 10539122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey.
    Rubenstein LM; Chrischilles EA; Voelker MD
    Pharmacoeconomics; 1997 Oct; 12(4):486-98. PubMed ID: 10174314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Direct Cost of Parkinson Disease at Juntendo Medical University Hospital, Japan.
    Yoritaka A; Fukae J; Hatano T; Oda E; Hattori N
    Intern Med; 2016; 55(2):113-9. PubMed ID: 26781008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Average annual cost of Parkinson's disease in a Brazilian multiethnic population.
    Bovolenta TM; Schumacher-Schuh AF; Santos-Lobato BLD; Godeiro Júnior CO; Silva DJD; Nicaretta D; Barbosa ER; Cardoso FEC; Della Coletta MV; Braga Neto P; Cury RG; Tumas V; Felicio AC
    Parkinsonism Relat Disord; 2023 Dec; 117():105897. PubMed ID: 37931350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study.
    Chay J; Tang RWC; Tan TE; Chan CM; Mathur R; Lee BJH; Chan HH; Sim SSKP; Farooqui S; Teo KYC; Fenwick EK; Lamoureux EL; Cheung CMG; Fenner BJ
    Eye (Lond); 2023 Dec; 37(18):3827-3833. PubMed ID: 37301937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Healthcare Data Analytics for Parkinson's Disease Patients: A Study of Hospital Cost and Utilization in the United States.
    Mukherjee S; Wu H; Jones J
    AMIA Annu Symp Proc; 2016; 2016():1950-1958. PubMed ID: 28269954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parkinson's disease in Sweden-resource use and costs by severity.
    Hjalte F; Norlin JM; Kellerborg K; Odin P
    Acta Neurol Scand; 2021 Nov; 144(5):592-599. PubMed ID: 34254292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Cross-Sectional Study on Socioeconomic Systems Supporting Outpatients With Parkinson's Disease in Japan.
    Matsushima A; Matsumoto A; Moriwaka F; Honma S; Itoh K; Yamada K; Shimohama S; Ohnishi H; Matsushima J; Mori M
    J Epidemiol; 2016; 26(4):185-90. PubMed ID: 26639753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic Burden Analysis of Parkinson's Disease Patients in China.
    Yang JX; Chen L
    Parkinsons Dis; 2017; 2017():8762939. PubMed ID: 28695039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic Review of the Cost of Illness of Parkinson's Disease from a Societal Perspective.
    Wijers A; Ravi A; Evers SMAA; Tissingh G; van Mastrigt GAPG
    Mov Disord; 2024 Nov; 39(11):1938-1951. PubMed ID: 39221849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A markov model approach assessing the cost of illness of generalized anxiety disorder in Canada.
    Bereza BG; Machado M; Papadimitropoulos M; Sproule B; Ravindran AV; Einarson TR
    Neurol Ther; 2012 Dec; 1(1):1. PubMed ID: 26000207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Annual Cost of Care of Parkinson's Disease and Its Determinants in North India - A Cost of Illness Study with Patient Perspective.
    Ola V; Puri I; Goswami D; Vibha D; Shukla G; Goyal V; Srivastava A; Behari M
    Ann Indian Acad Neurol; 2022; 25(4):660-663. PubMed ID: 36211186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical decision making for patients with Parkinson disease under Average Cost Criterion.
    Goulionis JE; Vozikis A
    Aust New Zealand Health Policy; 2009 Jun; 6():15. PubMed ID: 19549341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's disease.
    Nuijten MJ
    Pharmacoeconomics; 2000 Mar; 17(3):227-36. PubMed ID: 10947298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum to: 'Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050'.
    Png ME; Yoong J; Phan TP; Wee HL
    BMC Public Health; 2016 Jul; 16(1):589. PubMed ID: 27430212
    [No Abstract]   [Full Text] [Related]  

  • 58. Economic Burden of Dementia in Singapore: Preliminary Results.
    Wang VW; Kandiah N; Lin X; Wee HL
    Value Health; 2014 Nov; 17(7):A767. PubMed ID: 27202818
    [No Abstract]   [Full Text] [Related]  

  • 59. Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
    Chen HC; Wang CY; Chen HH; Liou HH
    PLoS One; 2022; 17(8):e0269006. PubMed ID: 35951654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson's disease: a costing study at a medical center in China.
    Yi ZM; Li XY; Wang YB; Wang RL; Ma QC; Zhao RS; Chen LC
    Ann Transl Med; 2022 Mar; 10(6):330. PubMed ID: 35433954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.